Overall, cDC1s possess potent capabilities to present antigens, activate CD8+ T cells via MHC-I, and activate Th1 and natural killer cells via IL-12, suggesting key roles in anti-tumor and anti-virus immunity (Figure 3) [34]. Here, CD8A is linked to neoplasm.